deutetrabenazine 18 MG 24HR Extended Release Oral Tablet

RxCUI: 2686153
RxNorm name: deutetrabenazine 18 MG 24HR Extended Release Oral Tablet
Display name: deutetrabenazine 18 MG 24HR Extended Release Oral Tablet
Full name: deutetrabenazine 18 MG 24HR Extended Release Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Austedo	DEUTETRABENAZINE	Teva Neuroscience, Inc.	7ea3c60a-45c7-44cc-afc2-d87fa53993c0	2025-02-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2686153

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7ea3c60a-45c7-44cc-afc2-d87fa53993c0	deutetrabenazine 18 MG 24HR Extended Release Oral Tablet	PSN	35	These highlights do not include all the information needed to use AUSTEDO XR or AUSTEDO safely and effectively. See full prescribing information for AUSTEDO XR and AUSTEDO . AUSTEDO XR ® (deutetrabenazine) extended-release tablets, for oral use AUSTEDO ® (deutetrabenazine) tablets, for oral use Initial U.S. Approval: 2017	20250228
7ea3c60a-45c7-44cc-afc2-d87fa53993c0	24 HR deutetrabenazine 18 MG Extended Release Oral Tablet	SCD	35	These highlights do not include all the information needed to use AUSTEDO XR or AUSTEDO safely and effectively. See full prescribing information for AUSTEDO XR and AUSTEDO . AUSTEDO XR ® (deutetrabenazine) extended-release tablets, for oral use AUSTEDO ® (deutetrabenazine) tablets, for oral use Initial U.S. Approval: 2017	20250228
7ea3c60a-45c7-44cc-afc2-d87fa53993c0	deutetrabenazine 18 MG 24 HR Extended Release Oral Tablet	SY	35	These highlights do not include all the information needed to use AUSTEDO XR or AUSTEDO safely and effectively. See full prescribing information for AUSTEDO XR and AUSTEDO . AUSTEDO XR ® (deutetrabenazine) extended-release tablets, for oral use AUSTEDO ® (deutetrabenazine) tablets, for oral use Initial U.S. Approval: 2017	20250228